Active Covid-19 infection and transmission after the first dose of the BNT162b2 mRNA vaccination in Saudi Arabia: A case report

A 47-year-old non-smoker male who has received the first dose of the BNT162b2 mRNA Covid-19 vaccine in Saudi Arabia. At day 3 post-vaccination, he tested negative for Covid-19 and travelled to Egypt. On day 12 he developed runny nose, body ache and fever, and he reportedly tested (PCR) negative for...

Full description

Bibliographic Details
Main Authors: Asem A. Allam, Anwar A. Sayed
Format: Article
Language:English
Published: Elsevier 2021-08-01
Series:Journal of Infection and Public Health
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1876034121001933
id doaj-e9b890cd8c404bd596382b5556c109b2
record_format Article
spelling doaj-e9b890cd8c404bd596382b5556c109b22021-07-31T04:38:12ZengElsevierJournal of Infection and Public Health1876-03412021-08-0114811231125Active Covid-19 infection and transmission after the first dose of the BNT162b2 mRNA vaccination in Saudi Arabia: A case reportAsem A. Allam0Anwar A. Sayed1Department of Internal Medicine and Critical Care, King Abdullah Bin Abdul-Aziz University Hospital, Princess Nourah Bint Abdulrahman University, Riyadh, Saudi ArabiaDepartment of Medical Microbiology and Immunology, Taibah University, Madinah, Saudi Arabia; Department of Surgery and Cancer, Imperial College London, London, United Kingdom; Corresponding author at: Department of Medical Microbiology and Immunology, Faculty of Medicine, Taibah University, Madinah, 42353, Saudi Arabia.A 47-year-old non-smoker male who has received the first dose of the BNT162b2 mRNA Covid-19 vaccine in Saudi Arabia. At day 3 post-vaccination, he tested negative for Covid-19 and travelled to Egypt. On day 12 he developed runny nose, body ache and fever, and he reportedly tested (PCR) negative for Covid-19 Upon his return to Saudi on day 15, his symptoms have worsened and he presented to the Emergency Department, at which he tested positive for Covid-19. The patient was overweight (BMI = 29), was not suffering from any comorbidities and was not taking any medication. Upon examination, he was vitally stable and his laboratory investigation only revealed a slightly increased Creatinine. His chest X-ray was unremarkable.His condition did not require hospital admission, so he was discharged and advised to home-isolate himself. Four days after his discharge, his entire household came to the hospital and tested positive for Covid-19.This is the first case report, in Saudi Arabia, of a person receiving the first dose of the BNT162b2 vaccine and got infected with Covid-19 afterwards. The report highlights the significance of receiving the second dose of the vaccine to be effective. It also demonstrates that those with a single dose mRNA vaccine, could get infected and transmit the infection.http://www.sciencedirect.com/science/article/pii/S1876034121001933COVID-19Vaccine efficacySaudi ArabiaPost-vaccination infectionSARS-CoV-2
collection DOAJ
language English
format Article
sources DOAJ
author Asem A. Allam
Anwar A. Sayed
spellingShingle Asem A. Allam
Anwar A. Sayed
Active Covid-19 infection and transmission after the first dose of the BNT162b2 mRNA vaccination in Saudi Arabia: A case report
Journal of Infection and Public Health
COVID-19
Vaccine efficacy
Saudi Arabia
Post-vaccination infection
SARS-CoV-2
author_facet Asem A. Allam
Anwar A. Sayed
author_sort Asem A. Allam
title Active Covid-19 infection and transmission after the first dose of the BNT162b2 mRNA vaccination in Saudi Arabia: A case report
title_short Active Covid-19 infection and transmission after the first dose of the BNT162b2 mRNA vaccination in Saudi Arabia: A case report
title_full Active Covid-19 infection and transmission after the first dose of the BNT162b2 mRNA vaccination in Saudi Arabia: A case report
title_fullStr Active Covid-19 infection and transmission after the first dose of the BNT162b2 mRNA vaccination in Saudi Arabia: A case report
title_full_unstemmed Active Covid-19 infection and transmission after the first dose of the BNT162b2 mRNA vaccination in Saudi Arabia: A case report
title_sort active covid-19 infection and transmission after the first dose of the bnt162b2 mrna vaccination in saudi arabia: a case report
publisher Elsevier
series Journal of Infection and Public Health
issn 1876-0341
publishDate 2021-08-01
description A 47-year-old non-smoker male who has received the first dose of the BNT162b2 mRNA Covid-19 vaccine in Saudi Arabia. At day 3 post-vaccination, he tested negative for Covid-19 and travelled to Egypt. On day 12 he developed runny nose, body ache and fever, and he reportedly tested (PCR) negative for Covid-19 Upon his return to Saudi on day 15, his symptoms have worsened and he presented to the Emergency Department, at which he tested positive for Covid-19. The patient was overweight (BMI = 29), was not suffering from any comorbidities and was not taking any medication. Upon examination, he was vitally stable and his laboratory investigation only revealed a slightly increased Creatinine. His chest X-ray was unremarkable.His condition did not require hospital admission, so he was discharged and advised to home-isolate himself. Four days after his discharge, his entire household came to the hospital and tested positive for Covid-19.This is the first case report, in Saudi Arabia, of a person receiving the first dose of the BNT162b2 vaccine and got infected with Covid-19 afterwards. The report highlights the significance of receiving the second dose of the vaccine to be effective. It also demonstrates that those with a single dose mRNA vaccine, could get infected and transmit the infection.
topic COVID-19
Vaccine efficacy
Saudi Arabia
Post-vaccination infection
SARS-CoV-2
url http://www.sciencedirect.com/science/article/pii/S1876034121001933
work_keys_str_mv AT asemaallam activecovid19infectionandtransmissionafterthefirstdoseofthebnt162b2mrnavaccinationinsaudiarabiaacasereport
AT anwarasayed activecovid19infectionandtransmissionafterthefirstdoseofthebnt162b2mrnavaccinationinsaudiarabiaacasereport
_version_ 1721247193740869632